Haw Par Corporation Limited

OTCPK:HAWP.F Stock Report

Market Cap: US$1.8b

Haw Par Past Earnings Performance

Past criteria checks 4/6

Haw Par has been growing earnings at an average annual rate of 5.4%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 1.8% per year. Haw Par's return on equity is 6.3%, and it has net margins of 98.1%.

Key information

5.4%

Earnings growth rate

5.4%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate1.8%
Return on equity6.3%
Net Margin98.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Haw Par makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:HAWP.F Revenue, expenses and earnings (SGD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24239234690
31 Mar 24236225700
31 Dec 23232217710
30 Sep 23215196650
30 Jun 23198175590
31 Mar 23190162570
31 Dec 22182148550
30 Sep 22176141570
30 Jun 22171134580
31 Mar 22156122540
31 Dec 21141110490
30 Sep 2111996410
30 Jun 219682340
31 Mar 21104101340
31 Dec 20111120350
30 Sep 20140118400
30 Jun 20181161490
31 Mar 20211206520
31 Dec 19244182610
30 Sep 19253190630
30 Jun 19257190640
31 Mar 19251182660
31 Dec 18238179620
30 Sep 18233173630
30 Jun 18226156640
31 Mar 18222125660
31 Dec 17223122680
30 Sep 17222128630
30 Jun 17218130580
31 Mar 17210128560
31 Dec 16202125530
30 Sep 16189124550
30 Jun 16187116560
31 Mar 16186184570
31 Dec 15179183530
30 Sep 15176183530
30 Jun 15167174510
31 Mar 15161120480
31 Dec 14154119470
30 Sep 14153124470
30 Jun 14152120470
31 Mar 14147112440

Quality Earnings: HAWP.F has high quality earnings.

Growing Profit Margin: HAWP.F's current net profit margins (98.1%) are higher than last year (88.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: HAWP.F's earnings have grown by 5.4% per year over the past 5 years.

Accelerating Growth: HAWP.F's earnings growth over the past year (33.8%) exceeds its 5-year average (5.4% per year).

Earnings vs Industry: HAWP.F earnings growth over the past year (33.8%) did not outperform the Pharmaceuticals industry 42%.

Return on Equity

High ROE: HAWP.F's Return on Equity (6.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 19:41
End of Day Share Price 2024/12/30 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Haw Par Corporation Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ramachandra KamathVirtua Research Inc.